Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05593081

Multicenter Study of Fulminant Type 1 Diabetes in China

Sponsor: Second Xiangya Hospital of Central South University

View on ClinicalTrials.gov

Summary

This study took FT1D(fulminant type 1 diabetes) as the research object, collected the cases of FT1D patients, and described the clinical characteristics of this type of disease. The HLA susceptibility genes of FT1D were identified by PCR and other techniques, taking age-sex-matched healthy subjects as controls and HLA genes as the research entry point.

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

240

Start Date

2022-05-20

Completion Date

2027-12-31

Last Updated

2022-10-25

Healthy Volunteers

Yes

Interventions

GENETIC

HLA

Distinguish based on clinical features

Locations (10)

Quanzhou First People's Hospital

Quanzhou, Fujian, China

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China

Guizhou Provincial People's Hospital

Zunyi, Guangzhou, China

Hainan Provincial People's Hospital

Haikou, Hainan, China

Changsha Central Hospital

Changsha, Hunan, China

Yancheng Third People's Hospital

Yancheng, Jiangs, China

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Yunnan Provincial People's Hospital

Kunming, Yunnan, China

The Second Xiangya Hospital of Central South University

Changsha, China